Abstract
Single and repeated intravenous administration of cyclophosphamide significantly decreased the candidacidal activity of rabbit peritoneal macrophages. Using higher doses of the drug, a more pronounced decrease, persisting up to 10 d, was observed. The phagoeytic index has not changed significantly 10 d after cyclophosphamide injection as compared with controls. No changes in the phagocytic activity were recorded. The decreased candidacidal activity may be one of the causes of serious microbial infections in cyclophosphamide-treated patients.
Similar content being viewed by others
References
Arai K., Kaibara N., Takagishi K., Hotokebuohi T., Arita C: Reversal antigen-induced resistance to collagen arthritis by cyclophosphamide.Clin. Immunol. Immunopathol. 43, 343–353 (1987).
Bach J.F., Storm T.B.: The mode of action of immunosuppressive agents.Research Monographs in Immunology, Vol. 9. Elsevier, Amstderdam—New York —Oxford 1985.
Bosch A., Lucena F., Paré S.R., Jofre J.: Compensation of immunosuppression by a bacterial immunostimulant (Broncho Vaxom) in mice.J. Immunopharmacol. 6, 323–338 (1984).
Enander I., Ahlstedt S., Nygren H.: Cyclophosphamide enhancement of delayed hypersen sitivity reactions in the lung.Int. Arch. Allergy Appl. Immunol. 79, 291–295 (1986).
Ettixger A.C., Htrata A.A.: Age dependent differential effects of evclophosphamide on natural antibody levels in chickens.Dev. Compar. Immunol. 6, 113–120 (1982).
Gadeberg O., Rhodes J.M., Olesen Larsen S.: The effect of various immunosuppressive agents on mouse peritoneal maerophages and on thein vitro phagocytosis ofEscherichin coli 04:K3:45 and degradation of125I labelled HSA antibody complexes by these cells.Immunology 28, 59–70 (1975).
Giordano M., Ishuriz M.: Enhancement of orythrophagocytosis by eyelophosphamide.Cell. Immunol. 81, 187–191 (1983).
Horn W., Hansman C., Kbderlix C.: An improved fluorochrome microassay for the, detection of living and non-living intracellular bacteria in human neutrophils.J. Immunol. Methods 83, 233–240 (1985).
Jones S.E., Grozea P.N., Miller T.P., Vah Slyck E.J., Baloerak S.P.: Chemotherapy with cyclophosphamide, doxorubicin, vineristine and prednisone alone and with levamisole or levamisole plus BCG for malignant lymphoma.J. Clin. Oncol. 3, 1318–1324 (1985).
Katz S.P., Lammie P.J.: Effect of cyclophosphamide on the immune responsiveness of birds, infected withBrughia pahangi.Inf. Immunity 43, 753–755 (1984).
Kotulová D.: Immunodeficiency diseases. (In Slovak)Lek. Obzor (Bratislava) 28, 659–662 (1979).
Mayer P., Walzl M.: Studies on lung infections, caused byPseudomonas aeruginoxa in mice treated with cyclophosphamide.Infection 11, 87–96 (1983).
Nawa Y., Owhashi M., Imai J., Abe T.: Chemotactic reactivity of eosinophils obtained from bone marrow and peritoneal cavity of cyclophosphamide treatedToxocara canis infected mice.Int. Arch. Allergy Appl. Immunol. 80, 412–416 (1986).
Pennington J.E.: Differential effects of cyclophosphamide and cortisone acetate on bronchoal veolar phagocytic cells population.Amer. Rev. Resp. Dis. 118, 319–325 (1978).
Rhodes J.M., Birch-Andersen A., Ravn H.: The effect of cyclophosphamide, methotrexate and X-irradiation on the ultrastructure and endocytic capacity of murine peritoneal maerophages.Acta Path. Scand. Sect. A 83, 444–453 (1975).
Smith H.R., Chused T.M., Steiberg A.D.: Cyclophosphamide induced changes in the MRL-Ipr mouse: effect upon cellular composition, immune function and disease.Clin. Immunol. Immunopathol. 30, 51–64 (1984).
Urbaniak S.J., White A.G., Barclay G.R., Wood S.M., Kay A.B.: Tests of immune function, p. 251 inHandbook of Experimental Immunology (D. M. Weir, ed.). Blackwell Sci. Publ., Oxford — London —Edinburgh —Melbourne 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kotulová, D., Žalkovičová, M. & Štefanovič, J. Effect of cyclophosphamide on the candidacidal activity of rabbit peritoneal macrophages. Folia Microbiol 33, 401–406 (1988). https://doi.org/10.1007/BF02925851
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02925851